The use of tumour markers CEA, CA-195 and CA-242 in evaluating the response to chemotherapy in patients with advanced colorectal cancer. (Q35976847)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8494712%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

title

The use of tumour markers CEA, CA-195 and CA-242 in evaluating the response to chemotherapy in patients with advanced colorectal cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8494712%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8494712%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

author name string

U Ward

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8494712%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

J N Primrose

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8494712%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

P J Finan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8494712%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

P Selby

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8494712%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

D A Purves

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8494712%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

E H Cooper

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8494712%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

language of work or name

English

0 references

publication date

1 May 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8494712%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

13 October 2019

http://eprints.whiterose.ac.uk/93482/

content deliverer

White Rose Research Online

0 references

published in

British Journal of Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8494712%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

volume

67

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8494712%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8494712%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

page(s)

1132-1135

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8494712%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bjc.1993.208

13 October 2019

exact match

0 references

cites work

Prospective monitoring trial for carcinoma of colon and rectum after surgical resection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968452

Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968452

Significance of a fall in serum CEA concentration in patients treated with cytotoxic chemotherapy for disseminated colorectal cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968452

The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968452

The Tumour Marker CA 195 in Colorectal and Pancreatic Cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968452

Sensitivity and specificity of CA242 in gastro-intestinal cancer. A comparison with CEA, CA50 and CA 19-9

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968452

Clinical update on the role of fluorouracil and recombinant interferon alfa-2a in the treatment of colorectal carcinoma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968452

Eighty-four potential second-look operations based on sequential carcinoembryonic antigen determinations and clinical investigations in patients with recurrent gastrointestinal cancer

24 September 2018

1 reference

12 December 2020

Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study

1 reference

12 December 2020

The value of CA 19-9 in gastric and colorectal carcinoma

1 reference

12 December 2020

Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1993.208

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8494712%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

13 October 2019

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8494712%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

1 reference